- Home
- REPL vs LQDT Comparison
REPL vs LQDT Comparison
Compare REPL & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- LQDT
- Stock Information
- Founded
- REPL 2015
- LQDT 1999
- Country
- REPL United States
- LQDT United States
- Employees
- REPL N/A
- LQDT N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- LQDT Catalog/Specialty Distribution
- Sector
- REPL Health Care
- LQDT Consumer Discretionary
- Exchange
- REPL Nasdaq
- LQDT Nasdaq
- Market Cap
- REPL 897.3M
- LQDT 965.6M
- IPO Year
- REPL 2018
- LQDT 2006
- Fundamental
- Price
- REPL $12.49
- LQDT $30.96
- Analyst Decision
- REPL Strong Buy
- LQDT Strong Buy
- Analyst Count
- REPL 6
- LQDT 2
- Target Price
- REPL $17.50
- LQDT $38.50
- AVG Volume (30 Days)
- REPL 1.3M
- LQDT 423.9K
- Earning Date
- REPL 02-06-2025
- LQDT 12-12-2024
- Dividend Yield
- REPL N/A
- LQDT N/A
- EPS Growth
- REPL N/A
- LQDT N/A
- EPS
- REPL N/A
- LQDT 0.63
- Revenue
- REPL N/A
- LQDT $363,318,000.00
- Revenue This Year
- REPL N/A
- LQDT $31.09
- Revenue Next Year
- REPL $300.41
- LQDT N/A
- P/E Ratio
- REPL N/A
- LQDT $49.14
- Revenue Growth
- REPL N/A
- LQDT 15.54
- 52 Week Low
- REPL $4.92
- LQDT $13.99
- 52 Week High
- REPL $17.00
- LQDT $36.00
- Technical
- Relative Strength Index (RSI)
- REPL 50.53
- LQDT 63.27
- Support Level
- REPL $11.19
- LQDT $30.27
- Resistance Level
- REPL $12.79
- LQDT $32.45
- Average True Range (ATR)
- REPL 0.70
- LQDT 1.61
- MACD
- REPL -0.14
- LQDT 0.34
- Stochastic Oscillator
- REPL 52.21
- LQDT 55.32
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.